Category: MassDevice.com Earnings Roundup
Stryker edges expectations on Wall Street despite a nearly 45% profit slide as it posts strong revenue growth and expands its footprint in Europe.
Investors eye 3rd-quarter data for evidence that Obamacare is driving an increase in procedure volumes.
(Reuters) – Hospitals and insurers are expected to give their clearest view yet on whether people are having more surgeries and other medical procedures during the next few weeks when they report earnings, according to investors who are closely watching U.S. medical services use.
Getinge lowers its sales forecast for the rest of the year amid uncertain earnings outlook, sending share prices plunging in Stockholm.
St. Jude Medical CEO Dan Starks is bullish on the potential for recent acquisition CardioMEMS to tap the $1 billion market for treating heart failure.
Baxter's 3rd-quarter profits beat expectations, driven by its medical product business, but shares slide on a lowered earnings forecast.
(Reuters) - Medical device and drug maker Baxter (NYSE:BAX) reported a higher-than-expected quarterly profit, as sales in its medical products business continued to grow.
St. Jude Medical's adjusted profits rise during the 3rd quarter as the company narrows its earnings guidance and lowers its sales outlook.
Johnson & Johnson's 2nd-quarter sales top forecasts, prompting the medical product giant to raise its full-year earnings guidance.